Free Trial
NYSE:STVN

Stevanato Group (STVN) Stock Price, News & Analysis

Stevanato Group logo
€21.99 -0.36 (-1.61%)
As of 10:04 AM Eastern

About Stevanato Group Stock (NYSE:STVN)

Key Stats

Today's Range
€21.28
€22.81
50-Day Range
€17.90
€23.02
52-Week Range
€16.56
€33.49
Volume
2,895 shs
Average Volume
341,533 shs
Market Capitalization
$6.66 billion
P/E Ratio
46.79
Dividend Yield
0.27%
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Remove Ads

Stevanato Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

STVN MarketRank™: 

Stevanato Group scored higher than 33% of companies evaluated by MarketBeat, and ranked 749th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Stevanato Group are expected to grow by 16.00% in the coming year, from €0.50 to €0.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Stevanato Group is 47.53, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.58.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Stevanato Group is 47.53, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.74.

  • Price to Earnings Growth Ratio

    Stevanato Group has a PEG Ratio of 7.18. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Stevanato Group has a P/B Ratio of 5.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.08% of the float of Stevanato Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Stevanato Group has a short interest ratio ("days to cover") of 9.5.
  • Change versus previous month

    Short interest in Stevanato Group has recently decreased by 1.96%, indicating that investor sentiment is improving.
  • Dividend Yield

    Stevanato Group has a dividend yield of 0.27%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Stevanato Group does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Stevanato Group is 12.50%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Stevanato Group will have a dividend payout ratio of 10.34% next year. This indicates that Stevanato Group will be able to sustain or increase its dividend.

  • Read more about Stevanato Group's dividend.
  • Percentage of Shares Shorted

    7.08% of the float of Stevanato Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Stevanato Group has a short interest ratio ("days to cover") of 9.5.
  • Change versus previous month

    Short interest in Stevanato Group has recently decreased by 1.96%, indicating that investor sentiment is improving.
  • News Sentiment

    Stevanato Group has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Stevanato Group this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for STVN on MarketBeat in the last 30 days.
Receive STVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stevanato Group and its competitors with MarketBeat's FREE daily newsletter.

STVN Stock News Headlines

Stevanato Group management to meet with Stephens
DOGE could send 6 AI stocks through the roof
Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement from Elon any day now … Thousands of government jobs could be replaced … By a new form of AI. Recently perfected by Musk and his team at xAI.
Stevanato: Ramping Syringe Demand, Buy Confirmed
See More Headlines

STVN Stock Analysis - Frequently Asked Questions

Stevanato Group's stock was trading at €21.79 at the beginning of 2025. Since then, STVN stock has increased by 2.5% and is now trading at €22.34.
View the best growth stocks for 2025 here
.

Stevanato Group S.p.A. (NYSE:STVN) released its quarterly earnings data on Thursday, March, 6th. The company reported $0.20 EPS for the quarter, meeting analysts' consensus estimates of $0.20. The business earned $352.68 million during the quarter, compared to analysts' expectations of $346.26 million. Stevanato Group had a trailing twelve-month return on equity of 9.86% and a net margin of 10.47%.

Stevanato Group (STVN) raised $720 million in an IPO on Friday, July 16th 2021. The company issued 32,000,000 shares at a price of $21.00-$24.00 per share.

Top institutional investors of Stevanato Group include Conestoga Capital Advisors LLC (2.67%), T. Rowe Price Investment Management Inc. (1.09%), TimesSquare Capital Management LLC (1.09%) and Thrivent Financial for Lutherans (0.92%).

Shares of STVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stevanato Group investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Fortinet (FTNT), Antero Resources (AR), CrowdStrike (CRWD), Walt Disney (DIS) and Onsemi (ON).

Company Calendar

Last Earnings
3/06/2025
Today
3/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSE:STVN
Fax
N/A
Employees
4,650
Year Founded
N/A

Profitability

Trailing P/E Ratio
47.53
Forward P/E Ratio
44.68
P/E Growth
7.18
Net Income
$157.62 million
Pretax Margin
14.11%

Debt

Sales & Book Value

Annual Sales
$1.10 billion
Cash Flow
€0.93 per share
Price / Cash Flow
23.97
Book Value
€4.15 per share
Price / Book
5.38

Miscellaneous

Free Float
300,723,000
Market Cap
$6.77 billion
Optionable
Optionable
Beta
0.60
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:STVN) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners